A two-stage cognitive theory of the positive symptoms of psychosis. Highlighting the role of lowered decision thresholds
Permanent link
https://hdl.handle.net/10037/10558Date
2016Type
Journal articleTidsskriftartikkel
Peer reviewed
Author
Moritz, Steffen; Pfuhl, Gerit; Luedtke, Thies; Menon, Mahesh; Balzan, Ryan P; Andreou, ChristinaAbstract
Objectives: We outline a two-stage heuristic account for the pathogenesis of the positive symptoms of
psychosis.
Methods: A narrative review on the empirical evidence of the liberal acceptance (LA) account of positive
symptoms is presented.
Hypothesis: At the heart of our theory is the idea that psychosis is characterized by a lowered decision
threshold, which results in the premature acceptance of hypotheses that a nonpsychotic individual
would reject. Once the hypothesis is judged as valid, counterevidence is not sought anymore due to a bias
against disconfirmatory evidence as well as confirmation biases, consolidating the false hypothesis. As a
result of LA, confidence in errors is enhanced relative to controls. Subjective probabilities are initially low
for hypotheses in individuals with delusions, and delusional ideas at stage 1 (belief formation) are often
fragile. In the course of the second stage (belief maintenance), fleeting delusional ideas evolve into fixed
false beliefs, particularly if the delusional idea is congruent with the emotional state and provides
“meaning”. LA may also contribute to hallucinations through a misattribution of (partially) normal
sensory phenomena. Interventions such as metacognitive training that aim to “plant the seeds of doubt”
decrease positive symptoms by encouraging individuals to seek more information and to attenuate
confidence. The effect of antipsychotic medication is explained by its doubt-inducing properties.
Limitations: The model needs to be confirmed by longitudinal designs that allow an examination of
causal relationships. Evidence is currently weak for hallucinations.
Conclusions: The theory may account for positive symptoms in a subgroup of patients. Future directions
are outlined.